| Name | Title | Contact Details |
|---|
Maxant Technologies is a Niles, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
cambridge dental group is a Dearborn Heights, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medpricer empowers industry-leading sourcing teams To help you with the continued pressure to optimize healthcare costs, our expert team and best-in-class technology triples your internal sourcing capacity and helps you cut purchased services expenses by an average of 24% without costing you a dime. You lead – We empower You retain the control of your goals and decisions. With the Medpricer methodology and $2.7 billion of Purchased Services sourcing experience, you extend your sourcing capability upfront and establish a best-in-class infrastructure to drive ongoing success in the future. Process more than you ever imagined We discover and optimize every Purchased Service category in your organization. Built on a time-tested methodology, our industry-leading custom contracting platform helps organizations consolidate spend data and manage negotiations more. Your GPO can`t help you like we can We give your team the expertise and flexibility of a consultant with the scalability of a GPO. Access our vendor-paid, independent custom contracting system to secure the right terms at the right price for all of your 400+ Purchased Service categories.
Regency Medical Supplies is a Burnaby, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.